Addex Therapeutics Ltd
ADXN
$6.07
$0.132.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.83% | -16.62% | -- | -- | -19.33% |
| Total Depreciation and Amortization | 355.56% | 3.85% | -- | -- | -91.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.09% | 18.10% | -- | -- | 20.67% |
| Change in Net Operating Assets | -302.62% | 8.70% | -- | -- | -103.89% |
| Cash from Operations | -23.63% | -16.32% | -- | -- | -2,385.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -105.73% | -- | -- | -- |
| Cash from Investing | -- | -105.73% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 15.79% | -5.56% | -- | -- | 0.00% |
| Issuance of Common Stock | -13.53% | -76.79% | -- | -- | -- |
| Repurchase of Common Stock | 50.77% | -140.74% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -240.00% | -66.67% | -- | -- | 1,882.14% |
| Cash from Financing | -13.52% | -79.02% | -- | -- | 5,550.00% |
| Foreign Exchange rate Adjustments | -100.00% | 9.52% | -- | -- | -145.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.21% | -382.91% | -- | -- | -6,656.47% |